Problem: Local train services operate in the central, southern and eastern sections of the city and are operated by South West Trains, with stations at Swaythling, St Denys, Millbrook, Redbridge, Bitterne, Sholing and Woolston. Plans were announced by Hampshire County Council in July 2009 for the introduction of tram-train running from Hythe (on what is now a freight-only line to Fawley) via Totton to Southampton Central Station and on to Fareham via St. Denys, and Swanwick. The proposal follows a failed plan to bring light rail to the Portsmouth and Gosport areas in 2005.
What company operates Southampton's local train service?
The answer is the following: South West Trains

Problem: The consolidation of the "hot AC" format contrasted with the near-demise of most other AC formats: Beginning with the 2005-2007 economic downturn and eventual recession most stations went for the more chart-based CHR, along with the top 40, urban and even Latino formats. Diminishing physical record sales also proved a major blow to the AC genre.
What AC format is still viable?
The answer is the following: hot AC

Problem: Saint Helena has a 10/3.6 Mbit/s internet link via Intelsat 707 provided by SURE. Serving a population of more than 4,000, this single satellite link is considered inadequate in terms of bandwidth.
What speed is Saint Helena internet access?
The answer is the following: 10/3.6 Mbit/s

Problem: Drug discovery and development is very expensive; of all compounds investigated for use in humans only a small fraction are eventually approved in most nations by government appointed medical institutions or boards, who have to approve new drugs before they can be marketed in those countries. In 2010 18 NMEs (New Molecular Entities) were approved and three biologics by the FDA, or 21 in total, which is down from 26 in 2009 and 24 in 2008. On the other hand, there were only 18 approvals in total in 2007 and 22 back in 2006. Since 2001, the Center for Drug Evaluation and Research has averaged 22.9 approvals a year. This approval comes only after heavy investment in pre-clinical development and clinical trials, as well as a commitment to ongoing safety monitoring. Drugs which fail part-way through this process often incur large costs, while generating no revenue in return. If the cost of these failed drugs is taken into account, the cost of developing a successful new drug (new chemical entity, or NCE), has been estimated at about 1.3 billion USD(not including marketing expenses). Professors Light and Lexchin reported in 2012, however, that the rate of approval for new drugs has been a relatively stable average rate of 15 to 25 for decades.
How many drugs were approved in 2007?
The answer is the following:
18 approvals